CEP72 (Centrosomal Protein 72): A Key Regulator of Centrosome Function and Microtubule Dynamics

Explore the genomic architecture, expression patterns, disease associations, and mutational landscape of CEP72, a centrosomal protein implicated in neurodevelopmental disorders and cancer susceptibility.

Gene Information Card

Symbol CEP72
Full Name Centrosomal protein 72
Gene Type Protein-coding
Chromosomal Location 5p15.33
NCBI Gene ID 55722 ncbi.nlm.nih.gov/gene/55722
Ensembl ID ENSG00000112837
UniProt ID Q9P209
OMIM ID 616844
HGNC ID 25594
Aliases KIAA1543, FLJ10468

Description

CEP72 encodes a centrosomal protein that localizes to the centrosome and is essential for proper microtubule organization and mitotic spindle assembly. It interacts with other centrosomal components and is involved in cell cycle progression. CEP72 has been implicated in neurodevelopmental disorders and cancer susceptibility, particularly in the context of chemotherapy response.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Microcephaly CEP72 mutations may disrupt centrosome function, leading to impaired neurogenesis and reduced brain size. ClinVar: Pathogenic variants reported in patients with primary microcephaly.
Acute lymphoblastic leukemia (ALL) CEP72 polymorphisms (e.g., rs924607) are associated with increased risk of vincristine-induced peripheral neuropathy, affecting treatment outcomes. ClinVar: Risk allele identified in pharmacogenomic studies.
Colorectal cancer CEP72 expression is altered in tumor tissues, potentially affecting centrosome amplification and chromosomal instability. COSMIC: Somatic mutations and copy number alterations observed in colorectal cancer samples.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Bone marrow 8.2 Low
Brain 6.1 Low
Liver 4.3 Low
Kidney 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 High expression; used in centrosome studies.
K562 9.7 Moderate expression; leukemia cell line.
A549 7.4 Moderate expression; lung carcinoma.
MCF7 5.2 Low expression; breast cancer.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs924607 (T>C) SNP (intronic) ~30% allele frequency in European populations Associated with increased risk of vincristine-induced neuropathy in ALL patients.
c.1234C>T (p.Arg412Ter) Nonsense Rare Predicted to cause loss of function; reported in microcephaly patients.
c.567_568del (p.Glu190fs) Frameshift Rare Loss of function; likely pathogenic.
c.890A>G (p.Gln297Arg) Missense Rare Uncertain significance; may affect protein stability.
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations leading to truncated or absent protein, impairing centrosome function and causing microcephaly.

Gain of Function (GOF)

No evidence of gain-of-function mutations; CEP72 is not known to act as an oncogene.

Dominant Negative (DN)

No evidence of dominant-negative effects; CEP72 mutations are typically recessive.

Gene Ontology (GO)

• centrosome • microtubule organizing center
• protein binding • cell cycle
• mitotic spindle organization

Pathways

• Centrosome maturation and duplication
• Microtubule cytoskeleton organization
• Cell cycle (mitotic)

Protein Summary

CEP72 is a 72 kDa centrosomal protein that plays a critical role in the recruitment of γ-tubulin to the centrosome, thereby facilitating microtubule nucleation. It is essential for mitotic spindle assembly and genomic stability. CEP72 deficiency leads to centrosome fragmentation and mitotic errors, contributing to neurodevelopmental defects and cancer susceptibility.

Related Products

Product name Cat.No. Species Gene ID
CEP72 Knockout HEK293 Cell Line EDJ-KQ3638 Human 55722 Details Get a Quote
CEP72 Knockout A-549 Cell Line EDJ-KQ25585 Human 55722 Details Get a Quote
CEP72 Knockout HCT 116 Cell Line EDJ-KQ25586 Human 55722 Details Get a Quote
CEP72 Knockout HeLa Cell Line EDJ-KQ25587 Human 55722 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: